FF
Insider
Foundation Fighting Blindness Retinal Degeneration Fund
DirectorFoundation Fighting Blindness Retinal Degeneration Fund (Director) filed 3 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 3 sales), most often in Opus Genetics, Inc. (IRD). The largest single filing was $8.6M of IRD (4,000,000 sh × $2.15, as filed), executed Dec 9 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$18.8M
shares × price, as filed
Last traded
Sep 30
Filed Oct 2
Median ADV $4.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $18.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
IRD
Opus Genetics, Inc.
IRD · 0 buys · 3 sells
3 filings
Recent filings
IRDSALE
Opus Genetics, Inc.
View filing →
$2.8M556,000 sh × $4.96
Exec Sep 30
Filed Oct 2 · 7:47 PM ET IRDSALE Opus Genetics, Inc. View filing → $7.4M
1,700,000 sh × $4.35
Exec May 18
Filed May 20 · 5:30 PM ET IRDSALE Opus Genetics, Inc. View filing → $8.6M
4,000,000 sh × $2.15
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET